Stryker’s SonicAnchor aims at improving soft tissue repair

Cara Livernois | | Health Exec | Economics

Stryker's Foot & Ankle have developed a new way to treat soft tissue repair with their SonicAnchor technology.

SonicAnchor, a bioresorbable polylactide polymer, is an implant that uses ultrasonic energy to liquefy the tip of the device and fill in cancellous bone, offering a more structurally stable fixation in seconds and lowering the risk of breaking during insertion. Testing on the device has shown a vast improvement in the load stability when compared to current methods

The technology can be used to conduct a range of procedures including: including Achilles tendon repair, lateral and medial stabilization, hallux valgus reconstruction, midfoot reconstruction, metatarsal ligament repair and digital tendon transfer.

"SonicAnchor is transforming the soft tissue experience, and we are excited Stryker is leading the way in providing this innovative solution to orthopedic surgeons. Its SonicFusion technology is unlike any other on the market," said Tom Popeck, vice president and general manager of Stryker's Foot and Ankle.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Report: 44% of adults in the U.S. are uninsured or underinsured
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation
Cardiologist demand is on the rise—can hospitals keep up?
Cardinal Health scoops up two companies for $3.9B
UnitedHealth defends $3.3B Amedisys acquisition
DOJ sues to block UnitedHealth’s $3.3B acquisition of home health giant

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”